Pharmacy

Here are 23 recent drug shortages and discontinuations, according to the FDA’s drug supply databases: Discontinued In shortage

Mirum Pharmaceuticals has entered a definitive agreement to acquire Bluejay Therapeutics — a deal that, if finalized, would add brelovitug, a phase 3-stage monoclonal antibody for chronic hepatitis delta virus, to its rare liver disease therapy pipeline. The $620 million…

President Donald Trump has directed HHS and the CDC to conduct a review of childhood vaccine recommendations abroad, aiming to align U.S. guidance with best practices from “peer, developed countries.” The directive came via a memorandum the president signed Dec.…

Cost Plus Drugs co-founder Mark Cuban and Humana CEO Jim Rechtin hinted at their companies are working together, Forbes reported Dec. 4. “We’re talking to CenterWell,” Mr. Cuban said during the Forbes Healthcare Summit. “I would say we are treating…

Becker’s asked pharmacy leaders across the U.S. one question: What innovation are you looking to scale for 2026 — and why? Their answers reveal a sector doubling down on automation, access and operational resilience. Access at the point of care…

The CDC’s Advisory Committee on Immunization Practices voted 8-3 in favor of limiting national recommendations on which infants should receive a hepatitis B vaccine at birth.  The panel voted Dec. 5 to exclusively recommend the first hepatitis B shot to…

Pharmacists are carving out roles beyond the pharmacy counter, and Sterling Elliott, PharmD, clinical pharmacist lead for ambulatory surgery at Chicago-based Northwestern Medicine, says the shift is “essential for the future of U.S. healthcare.” Speaking on the “Becker’s Pharmacy Leadership…

Mark Cuban Cost Plus Drugs has expanded its partnership with GraphiteRx to support the Cost Plus Marketplace for Businesses. The platform combines Cost Plus Drugs’ pricing model with GraphiteRx’s marketplace technology to help hospitals, pharmacies and clinics access essential medications…

Tracy Beth Høeg, MD, PhD, was named acting director of the FDA’s Center for Drug Evaluation and Research, effective Dec. 3. Dr. Høeg previously served as senior adviser for clinical sciences in the agency’s Office of the Commissioner and the…

The Anesthesia Patient Safety Foundation and the Institute for Safe Medication Practices issued a joint warning urging hospitals to eliminate vials and ampules of tranexamic acid from perioperative settings due to the risk of fatal wrong-drug, wrong-route errors, according to…